Minuto F - Search Results

1

Replacement therapy and cardiovascular diseases.

Boschetti M, Goglia U, Teti C, Esposito D, Giusti M, Minuto F, Ferone D. Boschetti M, et al. Among authors: minuto f. J Endocrinol Invest. 2008 Sep;31(9 Suppl):85-90. J Endocrinol Invest. 2008. PMID: 19020394 Review.

2

Pituitary tumor disappearance in a patient with newly diagnosed acromegaly primarily treated with octreotide LAR.

Resmini E, Murialdo G, Giusti M, Boschetti M, Minuto F, Ferone D. Resmini E, et al. Among authors: minuto f. J Endocrinol Invest. 2005 Feb;28(2):166-9. doi: 10.1007/BF03345361. J Endocrinol Invest. 2005. PMID: 15887864

3

Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.

Resmini E, Minuto F, Colao A, Ferone D. Resmini E, et al. Among authors: minuto f. Acta Diabetol. 2009 Jun;46(2):85-95. doi: 10.1007/s00592-009-0112-9. Epub 2009 Mar 26. Acta Diabetol. 2009. PMID: 19322513 Review.

4

Interactions between vitamin D and IGF-I: from physiology to clinical practice.

Ameri P, Giusti A, Boschetti M, Murialdo G, Minuto F, Ferone D. Ameri P, et al. Among authors: minuto f. Clin Endocrinol (Oxf). 2013 Oct;79(4):457-63. doi: 10.1111/cen.12268. Epub 2013 Aug 9. Clin Endocrinol (Oxf). 2013. PMID: 23789983 Review.

5

Autonomic nervous system and cardiovascular risk assessment during one year of growth hormone replacement therapy in adults with growth hormone deficiency.

Boschetti M, Casu M, Moretti S, Teti C, Albanese V, Albertelli M, Murialdo G, Minuto F, Ferone D. Boschetti M, et al. Among authors: minuto f. Hormones (Athens). 2015 Jan-Mar;14(1):134-41. doi: 10.14310/horm.2002.1510. Hormones (Athens). 2015. PMID: 25402370 Free article.

6

Circulating nitric oxide is modulated by recombinant human TSH administration during monitoring of thyroid cancer remnant.

Giusti M, Valenti S, Guazzini B, Molinari E, Cavallero D, Augeri C, Minuto F. Giusti M, et al. Among authors: minuto f. J Endocrinol Invest. 2003 Dec;26(12):1192-7. doi: 10.1007/BF03349156. J Endocrinol Invest. 2003. PMID: 15055471

7

Rationale for treating cancer with somatostatin analogs.

Minuto F, Ferone D, Arvigo M, Barreca A. Minuto F, et al. J Endocrinol Invest. 2003;26(8 Suppl):117-9. J Endocrinol Invest. 2003. PMID: 15233226 Review. No abstract available.

8

Current diagnostic guidelines for biochemical diagnosis of acromegaly.

Ferone D, Resmini E, Bocca L, Giusti M, Barreca A, Minuto F. Ferone D, et al. Among authors: minuto f. Minerva Endocrinol. 2004 Dec;29(4):207-23. Minerva Endocrinol. 2004. PMID: 15765030 Free article. Review. English, Italian.

9

A case-controlled study on the quality of life in a cohort of patients with history of differentiated thyroid carcinoma.

Giusti M, Sibilla F, Cappi C, Dellepiane M, Tombesi F, Ceresola E, Augeri C, Rasore E, Minuto F. Giusti M, et al. Among authors: minuto f. J Endocrinol Invest. 2005 Jul-Aug;28(7):599-608. doi: 10.1007/BF03347258. J Endocrinol Invest. 2005. PMID: 16218042

10

Circulating nitric oxide in women affected by weight loss amenorrhea during pulsatile gonadotropin-releasing hormone therapy.

Valenti S, Cavallero D, Fazzuoli L, Minuto F, Giusti M. Valenti S, et al. Among authors: minuto f. J Endocrinol Invest. 2005 Oct;28(9):773-8. doi: 10.1007/BF03347565. J Endocrinol Invest. 2005. PMID: 16370554

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

215 results

Search Page

Filters